| Ms Denise Renee Barefield Pendleton, MD | |
|
One Indeependence Plaza, Ste 810, Brookwood Ophthalmology Inc, Homewood, AL 35209 | |
| (205) 877-2921 | |
| (205) 877-8494 |
| Full Name | Ms Denise Renee Barefield Pendleton |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Location | One Indeependence Plaza, Ste 810, Homewood, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811972813 | NPI | - | NPPES |
| 051550639 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 4482 (Alabama) | Primary |
| 207W00000X | Ophthalmology | 019873 (Georgia) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Denise Renee Barefield Pendleton, MD 1032 2nd St W, Birmingham, AL 35204 Ph: (205) 873-0840 | Ms Denise Renee Barefield Pendleton, MD One Indeependence Plaza, Ste 810, Brookwood Ophthalmology Inc, Homewood, AL 35209 Ph: (205) 877-2921 |
News Archive
Two leading international organizations in the bone field are joining forces to establish a global series of training courses. The International Osteoporosis Foundation and the International Society for Clinical Densitometry have agreed to work together to develop an exciting new series of training courses which will set new standards in health education in the diagnosis and management of osteoporosis.
Rice University nanotechnology researchers have unveiled a solar-powered sterilization system that could be a boon for more than 2.5 billion people who lack adequate sanitation. The "solar steam" sterilization system uses nanomaterials to convert as much as 80 percent of the energy in sunlight into germ-killing heat.
An Australian-led global initiative to improve the diagnosis of genetic disorders and reduce errors in the reporting of genetic variations has been published today in the prestigious scientific journal Science.
S*BIO Pte Ltd today announced the initiation of multi-center Phase I clinical trials of SB1518, a potent and orally-active JAK2 inhibitor, in patients with leukemia and certain types of lymphoma.
› Verified 2 days ago
Mark Logan Hill, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 133 Raleigh Avenue, Homewood, AL 35209 Phone: 205-329-3092 |